Landmark prostate cancer screening trial launches in the UK
The first men have been invited to take part in Prostate Cancer UK’s TRANSFORM trial, kicking off the…
Age impacts systemic therapy outcomes in metastatic prostate cancer
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new…
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination…
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…
Cancer survivor says it is time all fathers got their prostate checked
Tim O’Neill remembers the phone call all too well. “It was 8 o’clock on a Tuesday night, letting…
Most Americans unaware that early prostate cancer shows no symptoms
A recent survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital…
PSMA PET/CT improves outcomes for men with recurrent prostate cancer
A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who…